Last Week At WLF

New Publications:

• Biotech-Enhanced Crops Face Ongoing Environmental Review Challenges
  By Kathryn Kusske Floyd, a Partner, Jay C. Johnson, Of Counsel, and Kristin Stastny, an Associate, all with the law firm Dorsey & Whitney LLP.
• Preparing For And Responding To SEC’S Whistleblower Program
  By Tonya Mitchum Grindon, Chair of the Corporate Governance/Securities Practice Group of the law firm Baker, Donelson, Bearman, Caldwell & Berkowitz, PC in Nashville, Tennessee.
• Wal-Mart v. Dukes: Rough Justice Without Due Process
  By Andrew J. Trask, Counsel in the Complex Commercial Litigation department at McGuireWoods LLP.

From The Legal Pulse:

• Lessons From the Rubashkin Amicus Debacle: The Government’s About-Face Calls for a DOJ Policy on Friend-of-the-Court Briefs – By Anthony J. Franze and R. Stanton Jones
• What Standards Will Apply to Federal Drug “Unsales” Force? – By Cory Andrews
• Five Questions for . . . Alexander Koff on Intellectual Property and China – An interview with Alexander P. Koff
• One More Update: Government Does An About Face on Amicus Brief in Rubashkin v. U.S. – The Legal Pulse
• Update: Campaign Against “Pay-for-Delay” Drug Patent Settlements Suffers Setback at Supreme Court – Glenn Lammi
• Update: At the Supreme Court, What Pro-Business Bias? – The Legal Pulse